Walmart Inc. (NYSE: WMT) (“Walmart”) is a multinational retail giant that operates a chain of hypermarkets, discount department stores, and grocery stores across the globe.
Walmart has more than 11,200 stores operating under 55 banners in 27 countries around the world. It has eCommerce websites in 10 countries. Each week, nearly 265 million customers and members shop at Walmart.
“Working with the world’s largest retailer is an honor,” said Koios CEO Chris Miller. “Walmart has begun carving out significant shelf space in select locations to build the next generation of better-for-you brands, and we are truly excited to be one of them. Making the world a healthier place is our mission and our relationship with Walmart will be a tremendous catalyst for reaching a mass audience for our brand.”
Koios developed a proprietary nootropic formula that has been shown to enhance brain function, including mental focus, memory, and concentration. Its formula includes superfoods such as lion’s mane mushroom, which contains bioactive substances with beneficial effects on the body, brain, heart, and gut. The Company produces the formula as a line of healthy, organic beverages and drink powders.
Launched last year, the Koios brand had been carried primarily in several health store chains, and various grocery chains until December when GNC – the largest health and wellness company in North America – initiated a vendor partnership.
Now, Walmart will soon be adding the Koios beverage line to its new functional beverage set. Initially, Koios products will be available in 1,094 Walmart locations across the United States. The retail giant will carry Pear Guava, Blood Orange and Peach Mango beverages. The products will also be available through Walmart’s online portal at www.walmart.com and will be available in stores April 1st of 2019.
Miller continues, “The vendor agreement is a pivotal development for a Denver-based startup that has become a standout in the functional beverage industry.”
Koios has been rapidly expanding its production capacity and its distribution network across Colorado and more widely across the United States. The Company works in the fast-growing ‘functional beverage’ space.
On behalf of the Board of Directors of the Company.
Chris Miller, CEO, and Director, KOIOS BEVERAGE CORP.
About Koios Beverage Corp.
The Company is an emerging functional beverage company which has an available distribution network of more than 5,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing CBD market. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/.
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: that the relationship between the Company and Walmart will be a tremendous catalyst for reaching a mass audience for the Company’s brand; that Walmart will soon be adding the Koios beverage line to its new functional beverage set; that Koios products will initially be available in 1,094 Walmart locations across the United States and carry certain flavors of Koios beverages; that Koios products will be available through Walmart’s online portal; statements with respect to the rapid expansion of the Company’s production capacity and its distribution network across Colorado and more widely across the United States; statements with respect to the growth and size of the functional beverage and CBD infused beverage markets; and statements regarding the business of the Company. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional and CBD infused beverage markets; (iii) consumer acceptance and adoption of functional beverages and CBD infused beverages as compared to other beverages; and (iv) other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.
For further information: Gina Burrus, 844-255-6467, firstname.lastname@example.org